Clinical Trials Directory

Trials / Completed

CompletedNCT02622464

Innovative Treatment for Scarred Vocal Cords by Local Injection of Autologous Stromal Vascular Fraction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Post-operative scarring on vocal cords is responsible for disorders of the vibration of the lining to the original dysphonia can be troublesome for the patient both in his private and professional life. There is no currently codified treatment for this type of situation and no therapeutic antifibrotic has been effective. Cell therapy is a promising new approach.After a liposuction and removing of mature adipocytes (40 to 60%), the remaining cells called stromal vascular fraction (SVF) could be isolated. SVF consists of a heterogeneous cell population including multipotent stem cells similar to mesenchymal stem cells present in bone marrow. The investigators hypothesis is that the trophic and antifibrotic properties of SVF could benefit patients with vocal cords scarring responsible for dysphonia.

Conditions

Interventions

TypeNameDescription
OTHERmicro injection of SVF in vocal cords

Timeline

Start date
2016-04-07
Primary completion
2018-06-07
Completion
2018-06-07
First posted
2015-12-04
Last updated
2019-03-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02622464. Inclusion in this directory is not an endorsement.

Innovative Treatment for Scarred Vocal Cords by Local Injection of Autologous Stromal Vascular Fraction (NCT02622464) · Clinical Trials Directory